News Daily News No Safety Concerns Seen With Inclisiran in Large ORION Analysis Michael O'Riordan December 06, 2023
News Daily News Short DAPT May Be Especially Beneficial for Women at High Bleeding Risk Yael L. Maxwell November 30, 2023
News Conference News TCT 2023 Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out Michael O'Riordan October 25, 2023
News Daily News Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata Yael L. Maxwell October 09, 2023
News Daily News Similar Outcomes With Enteric-Coated and Uncoated Aspirin: ADAPTABLE Todd Neale October 06, 2023
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Daily News Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted? Michael O'Riordan September 21, 2023
News Daily News Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA Todd Neale September 19, 2023
News Daily News Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability Todd Neale September 13, 2023
News Daily News ‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease Michael O'Riordan September 13, 2023
News Conference News ESC 2023 ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More Michael O'Riordan September 06, 2023
News Conference News ESC 2023 ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran Michael O'Riordan September 01, 2023
News Conference News ESC 2023 STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI Todd Neale August 26, 2023
News Daily News Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE Michael O'Riordan July 25, 2023
News Daily News More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA Michael O'Riordan July 18, 2023
News Daily News Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs Michael O'Riordan July 11, 2023
News Daily News Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit Michael O'Riordan June 30, 2023